STOCK TITAN

[Form 4] Neuraxis, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Neuraxis, Inc. (NRXS) Form 4 filing shows Director and 10% owner Brian P. Hannasch purchased 355,556 common shares on 07/01/2025 at $2.25 per share, an estimated cash outlay of roughly $0.8 million. The transaction was coded “P” (open-market purchase), executed directly, and lifts Hannasch’s total direct holdings to 1,131,522 shares.

Key take-aways:

  • The purchase represents a sizable vote of confidence by a control insider.
  • Post-transaction ownership exceeds one million shares, reinforcing alignment with minority shareholders.
  • No disposals or derivative transactions were reported.

The filing contains no additional financial data or explanatory notes beyond the standard certification.

La dichiarazione Form 4 di Neuraxis, Inc. (NRXS) mostra che il Direttore e azionista con oltre il 10% Brian P. Hannasch ha acquistato 355.556 azioni ordinarie il 01/07/2025 al prezzo di 2,25 $ per azione, per una spesa stimata di circa 0,8 milioni di dollari. L’operazione è stata classificata come “P” (acquisto sul mercato aperto), eseguita direttamente, e porta il totale delle azioni detenute direttamente da Hannasch a 1.131.522 azioni.

Punti chiave:

  • L’acquisto rappresenta un significativo segnale di fiducia da parte di un insider di controllo.
  • La proprietà post-operazione supera il milione di azioni, rafforzando l’allineamento con gli azionisti di minoranza.
  • Non sono state segnalate cessioni o operazioni con strumenti derivati.

La dichiarazione non contiene ulteriori dati finanziari o note esplicative oltre alla certificazione standard.

La presentación del Formulario 4 de Neuraxis, Inc. (NRXS) muestra que el Director y propietario del 10% Brian P. Hannasch compró 355,556 acciones comunes el 01/07/2025 a $2.25 por acción, con un desembolso estimado de aproximadamente $0.8 millones. La transacción fue clasificada como “P” (compra en mercado abierto), ejecutada directamente, y eleva la tenencia directa total de Hannasch a 1,131,522 acciones.

Puntos clave:

  • La compra representa un voto de confianza significativo por parte de un insider con control.
  • La propiedad tras la transacción supera el millón de acciones, reforzando la alineación con los accionistas minoritarios.
  • No se reportaron disposiciones ni transacciones con derivados.

La presentación no contiene datos financieros adicionales ni notas explicativas más allá de la certificación estándar.

Neuraxis, Inc. (NRXS) Form 4 제출 내역에 따르면 이사이자 10% 대주주인 Brian P. Hannasch가 2025년 7월 1일에 355,556 보통주를 주당 $2.25에 매입했으며, 약 80만 달러의 현금 지출이 추정됩니다. 이 거래는 “P”(시장 내 직접 매수)로 분류되었으며, Hannasch의 직접 보유 주식 총수는 1,131,522주로 증가했습니다.

주요 내용:

  • 이번 매수는 경영진 내부자의 강한 신뢰를 나타냅니다.
  • 거래 후 보유 주식이 백만 주를 넘어 소액 주주와의 이해관계가 강화됩니다.
  • 처분이나 파생상품 거래는 보고되지 않았습니다.

제출 서류에는 표준 인증 외에 추가 재무 데이터나 설명 노트가 포함되어 있지 않습니다.

Le dépôt du formulaire 4 de Neuraxis, Inc. (NRXS) indique que le directeur et détenteur de plus de 10% Brian P. Hannasch a acheté 355 556 actions ordinaires le 01/07/2025 au prix de 2,25 $ par action, pour une dépense estimée d’environ 0,8 million de dollars. La transaction a été codée « P » (achat sur le marché libre), exécutée directement, ce qui porte la détention directe totale de Hannasch à 1 131 522 actions.

Points clés :

  • L’achat représente un important signe de confiance de la part d’un initié contrôlant.
  • La détention post-transaction dépasse le million d’actions, renforçant l’alignement avec les actionnaires minoritaires.
  • Aucune cession ni transaction sur dérivés n’a été signalée.

Le dépôt ne contient pas de données financières supplémentaires ni de notes explicatives au-delà de la certification standard.

Neuraxis, Inc. (NRXS) Form 4 Einreichung zeigt, dass Direktor und 10%-Eigentümer Brian P. Hannasch am 01.07.2025 355.556 Stammaktien zu je 2,25 $ gekauft hat, was einen geschätzten Barausgabeaufwand von etwa 0,8 Millionen $ bedeutet. Die Transaktion wurde als „P“ (Kauf am offenen Markt) klassifiziert, direkt ausgeführt und erhöht Hannaschs Gesamtbestand an Direktbeteiligungen auf 1.131.522 Aktien.

Wichtige Erkenntnisse:

  • Der Kauf stellt ein bedeutendes Vertrauensvotum eines kontrollierenden Insiders dar.
  • Der Besitz nach der Transaktion übersteigt eine Million Aktien und stärkt die Ausrichtung mit Minderheitsaktionären.
  • Es wurden keine Veräußerungen oder Derivatgeschäfte gemeldet.

Die Einreichung enthält keine weiteren finanziellen Daten oder erläuternden Anmerkungen über die Standardzertifizierung hinaus.

Positive
  • Substantial insider purchase: 355,556 shares acquired, indicating confidence from a key insider.
  • Ownership increase: Beneficial holdings rise to 1,131,522 shares, strengthening alignment with shareholders.
Negative
  • None.

Insights

TL;DR: Large insider buy by 10% owner signals confidence; increases direct stake to 1.13 M shares, no negative flags.

The 355,556-share purchase at $2.25 adds about $0.80 M to Mr. Hannasch’s exposure, taking his stake above the psychological one-million-share mark. Given his dual role as Director and 10% holder, the move suggests conviction in NRXS’s near-term outlook and improves governance alignment. No sales or hedges were disclosed, limiting concerns over liquidity or mixed signals. From a market-psychology standpoint, substantial insider accumulation often precedes positive price action, although causality is never guaranteed.

La dichiarazione Form 4 di Neuraxis, Inc. (NRXS) mostra che il Direttore e azionista con oltre il 10% Brian P. Hannasch ha acquistato 355.556 azioni ordinarie il 01/07/2025 al prezzo di 2,25 $ per azione, per una spesa stimata di circa 0,8 milioni di dollari. L’operazione è stata classificata come “P” (acquisto sul mercato aperto), eseguita direttamente, e porta il totale delle azioni detenute direttamente da Hannasch a 1.131.522 azioni.

Punti chiave:

  • L’acquisto rappresenta un significativo segnale di fiducia da parte di un insider di controllo.
  • La proprietà post-operazione supera il milione di azioni, rafforzando l’allineamento con gli azionisti di minoranza.
  • Non sono state segnalate cessioni o operazioni con strumenti derivati.

La dichiarazione non contiene ulteriori dati finanziari o note esplicative oltre alla certificazione standard.

La presentación del Formulario 4 de Neuraxis, Inc. (NRXS) muestra que el Director y propietario del 10% Brian P. Hannasch compró 355,556 acciones comunes el 01/07/2025 a $2.25 por acción, con un desembolso estimado de aproximadamente $0.8 millones. La transacción fue clasificada como “P” (compra en mercado abierto), ejecutada directamente, y eleva la tenencia directa total de Hannasch a 1,131,522 acciones.

Puntos clave:

  • La compra representa un voto de confianza significativo por parte de un insider con control.
  • La propiedad tras la transacción supera el millón de acciones, reforzando la alineación con los accionistas minoritarios.
  • No se reportaron disposiciones ni transacciones con derivados.

La presentación no contiene datos financieros adicionales ni notas explicativas más allá de la certificación estándar.

Neuraxis, Inc. (NRXS) Form 4 제출 내역에 따르면 이사이자 10% 대주주인 Brian P. Hannasch가 2025년 7월 1일에 355,556 보통주를 주당 $2.25에 매입했으며, 약 80만 달러의 현금 지출이 추정됩니다. 이 거래는 “P”(시장 내 직접 매수)로 분류되었으며, Hannasch의 직접 보유 주식 총수는 1,131,522주로 증가했습니다.

주요 내용:

  • 이번 매수는 경영진 내부자의 강한 신뢰를 나타냅니다.
  • 거래 후 보유 주식이 백만 주를 넘어 소액 주주와의 이해관계가 강화됩니다.
  • 처분이나 파생상품 거래는 보고되지 않았습니다.

제출 서류에는 표준 인증 외에 추가 재무 데이터나 설명 노트가 포함되어 있지 않습니다.

Le dépôt du formulaire 4 de Neuraxis, Inc. (NRXS) indique que le directeur et détenteur de plus de 10% Brian P. Hannasch a acheté 355 556 actions ordinaires le 01/07/2025 au prix de 2,25 $ par action, pour une dépense estimée d’environ 0,8 million de dollars. La transaction a été codée « P » (achat sur le marché libre), exécutée directement, ce qui porte la détention directe totale de Hannasch à 1 131 522 actions.

Points clés :

  • L’achat représente un important signe de confiance de la part d’un initié contrôlant.
  • La détention post-transaction dépasse le million d’actions, renforçant l’alignement avec les actionnaires minoritaires.
  • Aucune cession ni transaction sur dérivés n’a été signalée.

Le dépôt ne contient pas de données financières supplémentaires ni de notes explicatives au-delà de la certification standard.

Neuraxis, Inc. (NRXS) Form 4 Einreichung zeigt, dass Direktor und 10%-Eigentümer Brian P. Hannasch am 01.07.2025 355.556 Stammaktien zu je 2,25 $ gekauft hat, was einen geschätzten Barausgabeaufwand von etwa 0,8 Millionen $ bedeutet. Die Transaktion wurde als „P“ (Kauf am offenen Markt) klassifiziert, direkt ausgeführt und erhöht Hannaschs Gesamtbestand an Direktbeteiligungen auf 1.131.522 Aktien.

Wichtige Erkenntnisse:

  • Der Kauf stellt ein bedeutendes Vertrauensvotum eines kontrollierenden Insiders dar.
  • Der Besitz nach der Transaktion übersteigt eine Million Aktien und stärkt die Ausrichtung mit Minderheitsaktionären.
  • Es wurden keine Veräußerungen oder Derivatgeschäfte gemeldet.

Die Einreichung enthält keine weiteren finanziellen Daten oder erläuternden Anmerkungen über die Standardzertifizierung hinaus.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hannasch Brian

(Last) (First) (Middle)
8815 W. STATE ROAD 46

(Street)
COLUMBUS IN 47201

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/01/2025 P 355,556 A $2.25 1,131,522 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Griffin D. Foster, Attorney-in-fact for Brian P. Hannasch 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Neuraxis (NRXS) shares did Brian Hannasch purchase?

355,556 common shares were bought on 07/01/2025.

At what price were the NRXS shares acquired?

The shares were purchased at $2.25 per share.

What is Brian Hannasch’s total ownership after the transaction?

He now directly holds 1,131,522 NRXS shares.

Was the transaction a purchase or sale?

It was coded “P”, indicating an open-market purchase.

Did the Form 4 list any derivative transactions?

No, no derivative securities were reported.
Neuraxis Inc

NYSE:NRXS

NRXS Rankings

NRXS Latest News

NRXS Latest SEC Filings

NRXS Stock Data

24.58M
6.55M
50.7%
5.57%
0.16%
Biotechnology
Electromedical & Electrotherapeutic Apparatus
Link
United States
CARMEL